Reversing T cell exhaustion improves effectiveness of myeloma immunotherapies

Дата публикации: 19-05-2026 13:44:55

Researchers at the Icahn School of Medicine at Mount Sinai, Bristol Myers Squibb (BMS), and the University of Oxford have discovered a way to give worn-out immune cells a second wind in the fight against multiple myeloma.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	New personalised therapy targets chronic blood cancer	0	7.58	02-07-2026
2	Investigadores de Mayo Clinic encuentran una nueva esperanza para el mieloma más difícil mediante inmunoterapia lista para usar	0	4	13-01-2026
3	A Trojan horse cancer therapy shows stunning results	0	7.27	30-01-2026
4	A hidden immune backup system could supercharge mRNA cancer vaccines	0	9.29	09-07-2026
5	Researchers uncover 'hidden key' to immunotherapy for intractable brain tumors	2	8	20-07-2026
6	Bessere Vorhersagbarkeit von Therapieergebnissen und Nebenwirkungen personalisierter Krebsimmuntherapien	0	11.69	11-12-2025
7	The secret reason some cancer treatments stop working	0	10.75	09-06-2026
8	New mechanism may help predict and improve macrophage-targeted cancer immunotherapy	0	7.03	14-08-2026
9	Talquetamab Plus Daratumumab and Pomalidomide and Talquetamab Plus Daratumumab Prolong PFS Among Previously Treated Patients with Relapsed Or Refractory Multiple Myeloma	0	5	02-07-2026
10	No OS Benefit from Continuous as Compared with Fixed-Duration Maintenance Therapy with Lenalidomide in Patients with Newly Diagnosed Multiple Myeloma	0	11.26	13-08-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 9.03. Источник: www.imm.ox.ac.uk.